Fermented oyster extract    (DrugBank: Oyster)

1 disease
IDDisease name (Link within this page)Number of trials
84Sarcoidosis1

84. Sarcoidosis    [ 143 clinical trials,   221 drugs,   (DrugBank: 79 drugs),   82 drug target genes,   165 drug target pathways]
Searched query = "Sarcoidosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 143 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04109911
(ClinicalTrials.gov)
September 25, 201927/9/2019Effect of Fermented Oyster Extract on Musculoskeletal Biomarkers in Relative Sarcopenia AdultsEffect of Fermented Oyster Extract on Musculoskeletal Biomarkers in Relative Sarcopenia Adults: a Randomized, Double-blinded, Placebo-controlled TrialMuscular SarcoidosisDietary Supplement: Fermented oyster extract;Dietary Supplement: PlaceboPusan National University Yangsan HospitalNULLRecruiting50 YearsN/AAll54N/AKorea, Republic of